Boehringer Ingelheim is Global Top Employer 2021
Boehringer Ingelheim is Global Top Employer 2021
Zoek op
Boehringer Ingelheim is erkend als Top Employer in Nederland
Het belang van een goede werkomgeving.
COVID-19: Boehringer Ingelheim schaalt op met Global Support Program
COVID-19: Boehringer Ingelheim schaalt op met Global Support Program
Boehringer Ingelheim ziet positief marktsentiment in 2020 ondanks invloed van COVID-19
Boehringer Ingelheim ziet positief marktsentiment in 2020 ondanks invloed van COVID-19
Parasiticiden
Read about Boehringer Ingelheim's Global Innovation and expertise in parasiticides for companion animals and cattle such as cats, dogs or horses.
Aftopor®/Aftovaxpur®/Aftovax®/Aftobov®Oleosa/Aftovaxpur®Doe
FMD vaccines with highly potent and purified antigens (Aftopor®, Aftovaxpur®) have potential marker properties that helps in endemic or emergency situations.
Wereldwijde innovatie voor diergezondheid
Animal Health Global Innovation Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our
bi_coc_2021_final_0.pdf
bi_coc_2021_final.pdf
enterisol-reg-nl-10302-2021.01.07.pdf
CorporateFactSheet_2021
Onze samenwerkingscultuur
We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives.
Onze bijdrage
Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come.
Boehringer Ingelheim verhuist in 2022 naar Amsterdam
Boehringer Ingelheim verhuist in 2022 naar Amsterdam
Vaccins
We work across multiple diseases and species to develop and deliver robust effective animal vaccines for companion animal, pets and cattle, read more here.
Het onderzoeksproces
A key part of our mission is to discover or identify new compounds, vaccines, technologies, disease processes, and infectious agents.
Therapeutica
We provide a disciplined scientific approach to the global discovery, development and delivery of therapeutics for all relevant animal species.
FRONTLINE® is ‘Merk van het jaar’ 2019-2020
FRONTLINE® is ‘Merk van het jaar’ 2019-2020
Boehringer Ingelheim wordt lid van IPC
Boehringer Ingelheim wordt lid van IPC
Nieuw consortium van ‘EU Innovative Medicines.....
Nieuw consortium van ‘EU Innovative Medicines Initiative (IMI)’ zet grootste database van pathologiebeelden op en versnelt ontwikkeling van kunstmatige intelligentie in geneeskunde
Our Approach
We are driven by the desire to improve human and animal health -– now and in the future. Therefore, we have developed our framework: Sustainable Development – For Generations.
Hoera, het is Internationale Kattendag!
Hoera, het is Internationale Kattendag!
Onze verbintenis
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals.
Nieuw Europees consortium versnelt de ontwikkeling van behandelingen tegen COVID-19
Nieuw Europees consortium versnelt de ontwikkeling van behandelingen tegen COVID-19
3D-geprinte hulpmiddelen bieden uitkomst voor mensen met sclerodermie
3D-geprinte hulpmiddelen bieden uitkomst voor mensen met sclerodermie